| Literature DB >> 25759247 |
Franziska Kellner1, Jeongwoon Kim2, Bernardo J Clavijo3, John P Hamilton2, Kevin L Childs2, Brieanne Vaillancourt2, Jason Cepela2, Marc Habermann2, Burkhard Steuernagel4, Leah Clissold3, Kirsten McLay3, Carol Robin Buell2, Sarah E O'Connor1.
Abstract
The medicinal plant Madagascar periwinkle, Catharanthus roseus (L.) G. Don, produces hundreds of biologically active monoterpene-derived indole alkaloid (MIA) metabolites and is the sole source of the potent, expensive anti-cancer compounds vinblastine and vincristine. Access to a genome sequence would enable insights into the biochemistry, control, and evolution of genes responsible for MIA biosynthesis. However, generation of a near-complete, scaffolded genome is prohibitive to small research communities due to the expense, time, and expertise required. In this study, we generated a genome assembly for C. roseus that provides a near-comprehensive representation of the genic space that revealed the genomic context of key points within the MIA biosynthetic pathway including physically clustered genes, tandem gene duplication, expression sub-functionalization, and putative neo-functionalization. The genome sequence also facilitated high resolution co-expression analyses that revealed three distinct clusters of co-expression within the components of the MIA pathway. Coordinated biosynthesis of precursors and intermediates throughout the pathway appear to be a feature of vinblastine/vincristine biosynthesis. The C. roseus genome also revealed localization of enzyme-rich genic regions and transporters near known biosynthetic enzymes, highlighting how even a draft genome sequence can empower the study of high-value specialized metabolites.Entities:
Keywords: Catharanthus roseus; alkaloid; genome; specialized metabolite; vinblastine
Mesh:
Substances:
Year: 2015 PMID: 25759247 DOI: 10.1111/tpj.12827
Source DB: PubMed Journal: Plant J ISSN: 0960-7412 Impact factor: 7.091